Such studies will be essential to clarify whether MELK directly phosphorylates Hippo pathway components, influences cytoskeletal organization, or acts through parallel signaling and epigenetic mechanisms to regulate YAP/TAZ activity in PAH. The gene discussed is MELK; the disease is pulmonary arterial hypertension.